PolyPeptide Group AG (XSWX:PPGN) Total Stockholders Equity : CHF359.5 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Total Stockholders Equity?

PolyPeptide Group AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF359.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PolyPeptide Group AG's Book Value per Share for the quarter that ended in Dec. 2023 was CHF10.90. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PolyPeptide Group AG's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.30.

PolyPeptide Group AG Total Stockholders Equity Historical Data

The historical data trend for PolyPeptide Group AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Total Stockholders Equity Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

163.13

192.01

438.31

416.14

359.52

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial					438.31	438.24	416.14	374.91	359.52

PolyPeptide Group AG (XSWX:PPGN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PolyPeptide Group AG's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(359.524	-	0)	/	32.9695
	=	10.90

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PolyPeptide Group AG's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(43.104	+	64.088)	/	359.524
	=	0.30

PolyPeptide Group AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines